China vs Ireland: Reported rate of new cervical cancer cases
China
9.06 per 100,000 women
in 2017
Ireland
9.63 per 100,000 women
in 2017
China rank
20th
Ireland rank
17th
Reported rate of new cervical cancer cases over time
- China
- Ireland
How they compare
Ireland currently reports 9.63 per 100,000 women against 9.06 per 100,000 women in China, a difference of 0.57 per 100,000 women.
That makes Ireland's figure about 1.1 times China's.
Across all 16 years both countries report, Ireland has been ahead every year.
China ranks 20th and Ireland ranks 17th of 46 countries.
Ireland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.14 per 100,000 women | 9.67 per 100,000 women | 4.53 per 100,000 women | Ireland |
| 2010s | 7.89 per 100,000 women | 9.98 per 100,000 women | 2.09 per 100,000 women | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, China or Ireland?
- Ireland, at 9.63 per 100,000 women against 9.06 per 100,000 women in China as of 2017.
- What is the difference in reported rate of new cervical cancer cases between China and Ireland?
- 0.57 per 100,000 women, with Ireland ahead.
- How many years of comparable data are there for China and Ireland?
- 16 years are reported by both, from 2002 to 2017.
- How do China and Ireland rank globally for reported rate of new cervical cancer cases?
- China ranks 20th and Ireland ranks 17th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.